Kidney Cancer Trial, Recruiting NCT06956144 Sponsor: The First Affiliated Hospital of Xiamen University Condition: Kidney Cancer
Back to Kidney Cancer

Kidney Cancer Trial, Recruiting

NCT06956144
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing to take part and are able to sign a consent form themselves, or have a legal representative who can sign on their behalf.
  • Adults between 18 and 75 years of age, of any gender.
  • People who have a suspected or confirmed primary kidney cancer diagnosis — supported by imaging or tissue testing — including specific types such as clear cell carcinoma, papillary renal cell carcinoma, or chromophobe renal cell carcinoma, and who are willing to have a tissue sample taken if this has not already been done.
  • People who have had a contrast-enhanced CT scan within the 2 weeks before joining the trial.
  • People whose general health and ability to carry out daily activities falls within an acceptable range, as measured by a standard medical scoring system called the ECOG scale (scores 0 to 3) (confirm with trial site).
  • People whose blood test results for liver function, kidney function, and blood cell counts fall within the ranges required by the trial (confirm with trial site for specific values).
  • People who are willing and able to attend follow-up visits and complete all required tests and appointments.

Who may not be able to join:

  • People who are pregnant or breastfeeding — all women of childbearing age will need to have a pregnancy test during the screening process.
  • People who are unable or unwilling to sign the consent form, and who do not have a legal representative able to do so.
  • People who currently have an acute (sudden or severe) illness affecting the whole body, or who have an imbalance in their body's electrolyte levels.
  • People who are unable to undergo a PET/CT scan — for example, those who cannot lie flat, or who have a fear of enclosed spaces or radiation.
  • People whom the research team considers unlikely to follow the study requirements, or who have other factors that make participation unsuitable.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-592-2137077

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The First Affiliated Hospital of Xiamen University
Registry
ClinicalTrials.gov
Start date
9 May 2025
Est. completion
30 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Evaluate the clinical diagnostic efficacy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov